Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New factor Xa inhibitors in development at Lilly

Oct. 15, 2002

Angiomax receives clearance in Canada

Oct. 11, 2002

Factor Xa inhibitors in early development at Boehringer Ingelheim

Oct. 10, 2002

Neutralase phase III protocol submitted

Oct. 9, 2002

Pharmion launches Innohep

Oct. 8, 2002

Bristol-Myers Squibb patent covers novel factor Xa inhibitors

Oct. 7, 2002

Preliminary results on use of argatroban for acute ischemic stroke

Oct. 3, 2002

Clopidogrel approved in E.U. for patients with acute coronary syndrome

Sep. 25, 2002

Novel antiplatelet agents with dual sGC-activating and PDE-inhibitory activity

Sep. 20, 2002

Pilot study for argatroban + tPA in acute ischemic stroke

Sep. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...